Skip to content
Allegro Ophthalmics - From Theory to Therapy
  • About
    • Company
    • Management
    • Board of Directors
    • Scientific Advisors
  • Science
  • Pipeline
    • Pipeline
    • Risuteganib
    • ALG-1007
    • Clinical Trials
  • Therapeutic Areas
    • Dry AMD
    • Dry Eye Disease
  • News
    • Press Releases
    • Allegro in the News
    • Events

VIDEO: Novel anti-integrin therapy

Posted on November 10, 2017 | by Allegro Ophthalmics, LLC

Baruch D. Kuppermann, MD, PhD, discusses Novel anti-integrin therapy at the Ophthalmology Innovation Summit @AAO 2017.

To view the video, please visit EyeWorld Video Reporter: “Novel anti-integrin therapy”

 

 

 

Posted in News Features
Allegro Ophthalmics - From Theory to Therapy

Setting the pace in ocular care
Read More >

Allegro Ophthalmics LLC
31473 Rancho Viejo Road, Suite 204
San Juan Capistrano, CA 92675, USA

Phone: +1 949.940.8130
Email: info@allegroeye.com

RECENT NEWS

Allegro Ophthalmics Receives FDA Agreement Under Special Protocol Assessment (SPA) for Phase 2b/3 Clinical Trial of Risuteganib for the Treatment of Intermediate Dry AMD
April 13, 2023

Allegro Ophthalmics Announces Presentation of Key Data Surrounding Dry AMD Pipeline Candidates, Treatment Considerations
February 10, 2023

  • About
  • Science
  • Pipeline
  • Therapeutic Areas
  • News
  • Careers
  • Contact Us
© 2023 Allegro Ophthalmics, LLC. All rights reserved. | Privacy Policy | Terms of Use